478 related articles for article (PubMed ID: 1802028)
1. Pharmacologic characterization of muscarinic receptors of insect brains.
Abdallah EA; Eldefrawi ME; Eldefrawi AT
Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
[TBL] [Abstract][Full Text] [Related]
2. Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
Honda H; Tomizawa M; Casida JE
J Agric Food Chem; 2007 Mar; 55(6):2276-81. PubMed ID: 17319687
[TBL] [Abstract][Full Text] [Related]
3. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
Munns M; Pennefather JN
Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
[TBL] [Abstract][Full Text] [Related]
6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
8. Ligand binding and functional characterization of muscarinic acetylcholine receptors on the TE671/RD human cell line.
Bencherif M; Lukas RJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):946-53. PubMed ID: 1646330
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic M2 receptors in rat brain labeled with [3H] AF-DX 384.
Castoldi AF; Fitzgerald B; Manzo L; Tonini M; Costa LG
Res Commun Chem Pathol Pharmacol; 1991 Dec; 74(3):371-4. PubMed ID: 1775727
[TBL] [Abstract][Full Text] [Related]
10. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
11. Antagonists and agonists interactions with the muscarinic receptor of the rat large airways.
Scott T; McMahon KK
J Pharmacol Exp Ther; 1988 Oct; 247(1):136-42. PubMed ID: 3171971
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
[TBL] [Abstract][Full Text] [Related]
13. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
14. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
Evans RA; Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
[TBL] [Abstract][Full Text] [Related]
15. Characterization of muscarinic receptors in human, guinea pig and rat lung.
Gies JP; Bertrand C; Vanderheyden P; Waeldele F; Dumont P; Pauli G; Landry Y
J Pharmacol Exp Ther; 1989 Jul; 250(1):309-15. PubMed ID: 2746503
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
Araujo DM; Lapchak PA; Quirion R
Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129
[TBL] [Abstract][Full Text] [Related]
17. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
Wang JX; Mei L; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
[TBL] [Abstract][Full Text] [Related]
19. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
20. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]